Karyopharm Announces FDA Approval of XPOVIO® (selinexor) for the Treatment of Patients with Relapsed or Refractory
Karyopharm Therapeutics Empresa Reclamada
Karyopharm is an innovation-driven pharmaceutical company whose core technology leverages the inhibition of nuclear export as a mechanism to treat patients with cancer and other medical conditions leer más
There is a lack of transparency in GMSA and it creates a competitive environment. While I have full trust in the executive team, I do not trust my GMSA leadership team. I recommend this survey is sent to all employees as many others may agree. I recommend investing in a program to retain talent
¿Qué son algunas de las mejores cosas de tu equipo?
Almost everyone on my team has strong work ethic and is collaborative.
Revisión
¿Qué es lo que te hace más feliz en el trabajo?
The potential to make an impact in patients and on the business
Revisión
¿Qué es lo más positivo de la cultura y el ambiente de tu empresa?
High performers are rewarded as they should be. People are recognized for their hard work and effort. Nothing gets done with an n of one. We are all achieving greatness together.
Revisión
¿Qué es lo mejor de tu paquéte de compensación?
I am compensated well however I am working harder than I ever have and I don’t feel that I am compensated at that level. I have done this same role at prior companies and been compensated the same
Revisión
¿Qué es lo que más te gusta de tu equipo directivo?
The executive team has a perfect balance of being committed to furthering the science and helping patients while understanding what it means to run a business. What Karyopharm has accomplished in the past decade is truly impressive and that speaks to diligence and commitment of this leadership team.
Revisión
Other Employee Reviews for Karyopharm Therapeutics
×